List of COVID-19 vaccine authorizations

National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.

Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.

Of the 40 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.

Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.

Oxford–AstraZeneca


The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, is a viral vector vaccine produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. Finland, Denmark, and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. Slovakia suspended its use after the death of a predisposed recipient. South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine. The AstraZeneca vaccine is the most widely accepted internationally, and the most popular in terms of total inoculated worldwide, over 1.3 billion. The AstraZeneca vaccine is administered in more countries than any other vaccine.

EMA countries
 * Full (5)
 * 1) Australia
 * 2) Brazil
 * 3) Canada
 * 4) India
 * 5) Israel
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden

CARPHA countries and entities
 * Emergency (170)
 * 1) Afghanistan
 * 2) Albania
 * 3) Algeria
 * 4) Andorra
 * 5) Angola
 * 6) Argentina
 * 7) Armenia
 * 8) Azerbaijan
 * 9) Bahrain
 * 10) Bangladesh
 * 11) Benin
 * 12) Bhutan
 * 13) Bolivia
 * 14) Bosnia and Herzegovina
 * 15) Botswana
 * 16) Brunei
 * 17) Burkina Faso
 * 18) Cambodia
 * 19) Cameroon
 * 20) Cape Verde
 * 21) Central African Republic
 * 22) Chile
 * 23) Colombia
 * 24) Comoros
 * 25) Congo-Brazzaville
 * 26) Congo-Kinshasa
 * 27) Costa Rica
 * 28) Djibouti
 * 29) Dominican Republic
 * 30) East Timor
 * 31) Ecuador
 * 32) Egypt
 * 33) El Salvador
 * 34) Eswatini
 * 35) Ethiopia
 * 36) Fiji
 * 37) Gambia
 * 38) Georgia
 * 39) Ghana
 * 40) Guatemala
 * 41) Guinea-Bissau
 * 42) Guinea
 * 43) Honduras
 * 44) Indonesia
 * 45) Iran
 * 46) Iraq
 * 47) Ivory Coast
 * 48) Japan
 * 49) Jordan
 * 50) Kenya
 * 51) Kiribati
 * 52) Kosovo
 * 53) Kuwait
 * 54) Kyrgyzstan
 * 55) Laos
 * 56) Lebanon
 * 57) Lesotho
 * 58) Liberia
 * 59) Libya
 * 60) Madagascar
 * 61) Malawi
 * 62) Malaysia
 * 63) Maldives
 * 64) Mali
 * 65) Mauritania
 * 66) Mauritius
 * 67) Mexico
 * 68) Micronesia
 * 69) Moldova
 * 70) Mongolia
 * 71) Montenegro
 * 72) Morocco
 * 73) Mozambique
 * 74) Myanmar
 * 75) Namibia
 * 76) Nauru
 * 77) Nepal
 * 78) New Zealand
 * 79) Nicaragua
 * 80) Niger
 * 81) Nigeria
 * 82) North Macedonia
 * 83) Oman
 * 84) Pakistan
 * 85) Palestine
 * 86) Panama
 * 87) Papua New Guinea
 * 88) Paraguay
 * 89) Peru
 * 90) Philippines
 * 91) Qatar
 * 92) Rwanda
 * 93) Samoa
 * 94) São Tomé and Príncipe
 * 95) Saudi Arabia
 * 96) Senegal
 * 97) Serbia
 * 98) Seychelles
 * 99) Sierra Leone
 * 100) Singapore (restricted)
 * 101) Solomon Islands
 * 102) Somalia
 * 103) South Korea
 * 104) South Sudan
 * 105) Sri Lanka
 * 106) Sudan
 * 107) Syria
 * 108) Taiwan
 * 109) Tajikistan
 * 110) Thailand
 * 111) Togo
 * 112) Tonga
 * 113) Tunisia
 * 114) Turkmenistan
 * 115) Tuvalu
 * 116) Uganda
 * 117) Ukraine
 * 118) United Arab Emirates
 * 119) United Kingdom
 * 120) Uruguay
 * 121) Uzbekistan
 * 122) Vanuatu
 * 123) Vietnam
 * 124) Yemen
 * 125) Zambia
 * 126) Zimbabwe
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities EMA countries
 * Cook Islands
 * Falkland Islands
 * French Polynesia
 * Greenland
 * Guadeloupe
 * Guernsey
 * Isle of Man
 * Jersey
 * Northern Cyprus
 * Pitcairn
 * Saint Helena, Ascension and Tristan da Cunha
 * Wallis and Futuna
 * World Health Organization
 * Travel-only
 * Hong Kong
 * Switzerland
 * United States
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden

Pfizer–BioNTech


The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.

Original
EMA countries Non-country entities CARPHA countries and entities
 * Full (39)
 * 1) Australia
 * 2) Brazil
 * 3) Canada
 * 4) Marshall Islands
 * 5) Micronesia
 * 6) New Zealand
 * 7) Palau
 * 8) Saudi Arabia
 * 9) Switzerland
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden
 * Hong Kong
 * Emergency (145)
 * 1) Afghanistan
 * 2) Albania
 * 3) Algeria
 * 4) Andorra
 * 5) Argentina
 * 6) Armenia
 * 7) Azerbaijan
 * 8) Bahrain
 * 9) Bangladesh
 * 10) Benin
 * 11) Bhutan
 * 12) Bolivia
 * 13) Bosnia and Herzegovina
 * 14) Botswana
 * 15) Brunei
 * 16) Cambodia
 * 17) Cameroon
 * 18) Cape Verde
 * 19) Chile
 * 20) China (For German citizens)
 * 21) Colombia
 * 22) Congo-Kinshasa
 * 23) Costa Rica
 * 24) Djibouti
 * 25) Dominican Republic
 * 26) East Timor
 * 27) Ecuador
 * 28) Egypt
 * 29) El Salvador
 * 30) Eswatini
 * 31) Fiji
 * 32) Gabon
 * 33) Georgia
 * 34) Ghana
 * 35) Guatemala
 * 36) Guinea
 * 37) Honduras
 * 38) Indonesia
 * 39) Iraq
 * 40) Israel
 * 41) Ivory Coast
 * 42) Japan
 * 43) Jordan
 * 44) Kazakhstan
 * 45) Kenya
 * 46) Kosovo
 * 47) Kuwait
 * 48) Kyrgyzstan
 * 49) Laos
 * 50) Lebanon
 * 51) Libya
 * 52) Malawi
 * 53) Malaysia
 * 54) Maldives
 * 55) Mexico
 * 56) Moldova
 * 57) Monaco
 * 58) Mongolia
 * 59) Montenegro
 * 60) Morocco
 * 61) Namibia
 * 62) Nepal
 * 63) Nicaragua
 * 64) Nigeria
 * 65) North Macedonia
 * 66) Oman
 * 67) Pakistan
 * 68) Palestine
 * 69) Panama
 * 70) Papua New Guinea
 * 71) Paraguay
 * 72) Peru
 * 73) Philippines
 * 74) Qatar
 * 75) Rwanda
 * 76) Samoa
 * 77) San Marino
 * 78) Serbia
 * 79) Singapore
 * 80) Somalia
 * 81) South Africa
 * 82) South Korea
 * 83) Sri Lanka
 * 84) Sudan
 * 85) Syria
 * 86) Taiwan
 * 87) Tajikistan
 * 88) Tanzania
 * 89) Thailand
 * 90) Tonga
 * 91) Tunisia
 * 92) Turkey
 * 93) Uganda
 * 94) Ukraine
 * 95) United Arab Emirates
 * 96) United Kingdom
 * 97) Uruguay
 * 98) Uzbekistan
 * 99) Vatican City
 * 100) Vietnam
 * 101) Yemen
 * 102) Zambia
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities
 * American Samoa
 * Cook Islands
 * Faroe Islands
 * French Polynesia
 * Gibraltar
 * Greenland
 * Guadeloupe
 * Guam
 * Guernsey
 * Isle of Man
 * Jersey
 * Macau
 * Martinique
 * New Caledonia
 * Niue
 * Northern Cyprus
 * Northern Mariana Islands
 * Puerto Rico
 * Tokelau
 * World Health Organization

Bivalent original–BA.1

 * 1) Japan

EMA countries Non-country entities
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden
 * World Health Organization

Bivalent original–BA.4/5
EMA countries Non-country entities
 * 1) Canada
 * 2) China (For German citizens)
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden
 * Hong Kong
 * Macau
 * World Health Organization

XBB.1.5

 * 1) United States

Janssen


 The Janssen COVID-19 vaccine is a viral vector vaccine produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups. The United States began use of the Janssen vaccine in March 2021, but discouraged use in favor of other available vaccines in December 2021 due to the risk of a rare clotting disorder. The Janssen vaccine became unavailable in the United States in May 2023 after all existing doses expired.


 * Full (4)
 * 1) Australia (not used)
 * 2) Brazil
 * 3) Canada
 * 4) Switzerland

EMA countries CARPHA countries and entities
 * Emergency (132)
 * 1) Afghanistan
 * 2) Andorra
 * 3) Argentina
 * 4) Bahamas
 * 5) Bahrain
 * 6) Bangladesh
 * 7) Benin
 * 8) Bolivia
 * 9) Botswana
 * 10) Brunei
 * 11) Burkina Faso
 * 12) Cambodia
 * 13) Cameroon
 * 14) Central African Republic
 * 15) Chile
 * 16) Colombia
 * 17) Congo-Kinshasa
 * 18) Djibouti
 * 19) Egypt
 * 20) Eswatini
 * 21) Ethiopia
 * 22) Gabon
 * 23) Ghana
 * 24) Guinea
 * 25) Honduras
 * 26) India
 * 27) Indonesia
 * 28) Iran
 * 29) Iraq
 * 30) Ivory Coast
 * 31) Jordan
 * 32) Kenya
 * 33) Kuwait
 * 34) Laos
 * 35) Lebanon
 * 36) Lesotho
 * 37) Liberia
 * 38) Libya
 * 39) Madagascar
 * 40) Malawi
 * 41) Malaysia
 * 42) Maldives
 * 43) Mali
 * 44) Marshall Islands
 * 45) Mauritania
 * 46) Mexico
 * 47) Micronesia
 * 48) Moldova
 * 49) Monaco
 * 50) Morocco
 * 51) Mozambique
 * 52) Namibia
 * 53) Nepal
 * 54) New Zealand
 * 55) Nicaragua
 * 56) Nigeria
 * 57) Oman
 * 58) Pakistan
 * 59) Palau
 * 60) Palestine
 * 61) Papua New Guinea
 * 62) Peru
 * 63) Philippines
 * 64) Qatar
 * 65) Rwanda
 * 66) Saudi Arabia
 * 67) Senegal
 * 68) Singapore (restricted)
 * 69) Somalia
 * 70) South Africa
 * 71) South Korea
 * 72) South Sudan
 * 73) Sudan
 * 74) Syria
 * 75) Taiwan (not used)
 * 76) Tanzania
 * 77) Thailand
 * 78) Tunisia
 * 79) Uganda
 * 80) Ukraine
 * 81) United Arab Emirates
 * 82) United Kingdom
 * 83) United States (no longer available as of May 7, 2023 )
 * 84) Vanuatu
 * 85) Vietnam
 * 86) Yemen
 * 87) Zambia
 * 88) Zimbabwe
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities
 * American Samoa
 * French Polynesia
 * Greenland
 * Guam
 * New Caledonia
 * Northern Cyprus
 * Northern Mariana Islands
 * Puerto Rico
 * Africa Regulatory Taskforce
 * World Health Organization
 * Travel-only
 * Hong Kong
 * Japan
 * Turkey

Moderna
<section begin="modernaauthmap" />

<section end="modernaauthmap" /> The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations. The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.

Original
EMA countries
 * Full (<section begin="Moderna_FN" />34<section end="Moderna_FN" />)
 * 1) Australia
 * 2) Canada
 * 3) Switzerland
 * 4) United Kingdom
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden

CARPHA countries and entities
 * Emergency (<section begin="Moderna_EN" />116<section end="Moderna_EN" />)
 * 1) Andorra
 * 2) Argentina
 * 3) Armenia
 * 4) Bahrain
 * 5) Bangladesh
 * 6) Bhutan
 * 7) Botswana
 * 8) Bolivia
 * 9) Brazil
 * 10) Brunei
 * 11) Cape Verde
 * 12) Chile
 * 13) Colombia
 * 14) Congo-Brazzaville
 * 15) Congo-Kinshasa
 * 16) Djibouti
 * 17) Egypt
 * 18) El Salvador
 * 19) Fiji
 * 20) Ghana
 * 21) Guatemala
 * 22) Honduras
 * 23) India
 * 24) Indonesia
 * 25) Iran
 * 26) Iraq
 * 27) Israel
 * 28) Japan
 * 29) Jordan
 * 30) Kenya
 * 31) Kuwait
 * 32) Kyrgyzstan
 * 33) Lebanon
 * 34) Libya
 * 35) Malawi
 * 36) Malaysia
 * 37) Maldives
 * 38) Marshall Islands
 * 39) Mexico
 * 40) Micronesia
 * 41) Moldova
 * 42) Monaco
 * 43) Mongolia
 * 44) Morocco
 * 45) Nepal
 * 46) Nigeria
 * 47) Oman
 * 48) Pakistan
 * 49) Palau
 * 50) Palestine
 * 51) Paraguay
 * 52) Peru
 * 53) Philippines
 * 54) Qatar
 * 55) Rwanda
 * 56) Saudi Arabia
 * 57) Serbia
 * 58) Singapore
 * 59) South Korea
 * 60) Sri Lanka
 * 61) Sudan
 * 62) Syria
 * 63) Taiwan
 * 64) Tajikistan
 * 65) Thailand
 * 66) Tunisia
 * 67) Uganda
 * 68) Ukraine
 * 69) United Arab Emirates
 * 70) Uzbekistan
 * 71) Vietnam
 * 72) Yemen
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities
 * American Samoa
 * Faroe Islands
 * Greenland
 * Guadeloupe
 * Guam
 * Guernsey
 * Isle of Man
 * Jersey
 * Northern Mariana Islands
 * Puerto Rico
 * Wallis and Futuna
 * World Health Organization
 * Travel-only
 * Hong Kong
 * New Zealand
 * Turkey

Bivalent original–BA.1

 * 1) Australia
 * 2) Canada
 * 3) Japan
 * 4) Singapore
 * 5) Switzerland
 * 6) Taiwan
 * 7) United Kingdom

EMA countries
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden

Bivalent original–BA.4/5

 * 1) Brazil
 * 2) Taiwan

XBB.1.5

 * 1) Brazil
 * 2) United States

Sinopharm BIBP
The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products.


 * Full (<section begin="Sinopharm BIBP_FN"/>4<section end="Sinopharm BIBP_FN"/>)
 * 1) Bahrain
 * 2) China
 * 3) Seychelles
 * 4) United Arab Emirates

CARPHA countries and entities
 * Emergency (<section begin="Sinopharm BIBP_EN" />111<section end="Sinopharm BIBP_EN" />)
 * 1) Afghanistan
 * 2) Algeria
 * 3) Angola
 * 4) Argentina
 * 5) Armenia
 * 6) Bangladesh
 * 7) Belarus
 * 8) Bhutan
 * 9) Bolivia
 * 10) Bosnia and Herzegovina
 * 11) Brazil
 * 12) Brunei
 * 13) Burkina Faso
 * 14) Burundi
 * 15) Cambodia
 * 16) Cameroon
 * 17) Cape Verde
 * 18) Chad
 * 19) Comoros
 * 20) Congo-Brazzaville
 * 21) Cuba
 * 22) Djibouti
 * 23) Dominican Republic
 * 24) Egypt
 * 25) El Salvador
 * 26) Equatorial Guinea
 * 27) Ethiopia
 * 28) Gabon
 * 29) Gambia
 * 30) Georgia
 * 31) Guinea-Bissau
 * 32) Guinea
 * 33) Hungary
 * 34) Indonesia
 * 35) Iran
 * 36) Iraq
 * 37) Ivory Coast
 * 38) Jordan
 * 39) Kazakhstan
 * 40) Kenya
 * 41) Kiribati
 * 42) Kuwait
 * 43) Kyrgyzstan
 * 44) Laos
 * 45) Lebanon
 * 46) Lesotho
 * 47) Libya
 * 48) Madagascar
 * 49) Malawi
 * 50) Malaysia
 * 51) Maldives
 * 52) Mauritania
 * 53) Mauritius
 * 54) Mexico
 * 55) Moldova
 * 56) Mongolia
 * 57) Montenegro
 * 58) Morocco
 * 59) Mozambique
 * 60) Myanmar
 * 61) Namibia
 * 62) Nepal
 * 63) Nicaragua
 * 64) Niger
 * 65) Nigeria
 * 66) North Korea
 * 67) North Macedonia
 * 68) Oman
 * 69) Pakistan
 * 70) Palestine
 * 71) Papua New Guinea
 * 72) Paraguay
 * 73) Peru
 * 74) Philippines
 * 75) Qatar
 * 76) Rwanda
 * 77) Senegal
 * 78) Serbia
 * 79) Sierra Leone
 * 80) Singapore
 * 81) Solomon Islands
 * 82) Somalia
 * 83) South Sudan
 * 84) Sri Lanka
 * 85) Sudan
 * 86) Syria
 * 87) Tanzania
 * 88) Thailand
 * 89) Tunisia
 * 90) Turkmenistan
 * 91) Vanuatu
 * 92) Venezuela
 * 93) Vietnam
 * 94) Yemen
 * 95) Zambia
 * 96) Zimbabwe
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities
 * Macau
 * World Health Organization


 * Travel-only


 * Andorra
 * Australia
 * Austria (only for entry)
 * Bulgaria
 * Canada
 * Chile
 * Costa Rica
 * Croatia
 * Cyprus
 * Czech Republic (only for Hungarian citizens and EU nationals vaccinated in Hungary)
 * Estonia (only if approved in a person's country of origin)
 * Finland
 * Greece
 * Grenada
 * Hong Kong
 * Iceland
 * Ireland
 * Japan
 * Latvia
 * Liechtenstein
 * New Zealand
 * Oman
 * Panama
 * Portugal (only in Madeira)
 * Qatar
 * Saudi Arabia (for short visits, Hajj and Umrah only)
 * Slovakia
 * Slovenia
 * South Korea
 * Spain
 * St. Kitts and Nevis
 * St. Lucia
 * St. Vincent and the Grenadines
 * Sweden
 * Switzerland
 * The Netherlands
 * Turkey
 * Ukraine
 * United Kingdom
 * United States
 * Uruguay (only if approved in a person's country of origin)

Sputnik V
<section begin="sputnikauthmap" />

<section end="sputnikauthmap" /> The Sputnik V COVID-19 vaccine is a viral vector vaccine produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.
 * Full (<section begin="Sputnik V_FN" />3<section end="Sputnik V_FN" />)
 * 1) Russia
 * 2) Turkmenistan
 * 3) Uzbekistan


 * Emergency (<section begin="Sputnik V_EN" />76<section end="Sputnik V_EN" />)
 * 1) Albania
 * 2) Algeria
 * 3) Angola
 * 4) Antigua and Barbuda
 * 5) Argentina
 * 6) Armenia
 * 7) Azerbaijan
 * 8) Bahrain
 * 9) Bangladesh
 * 10) Belarus
 * 11) Bolivia
 * 12) Bosnia and Herzegovina
 * 13) Brazil (restricted)
 * 14) Cambodia
 * 15) Cameroon
 * 16) Chile
 * 17) Congo-Brazzaville
 * 18) Djibouti
 * 19) Ecuador
 * 20) Egypt
 * 21) Gabon
 * 22) Gambia
 * 23) Ghana
 * 24) Guatemala
 * 25) Guinea
 * 26) Guyana
 * 27) Honduras
 * 28) Hungary
 * 29) India
 * 30) Indonesia
 * 31) Iran
 * 32) Iraq
 * 33) Ivory Coast
 * 34) Jordan
 * 35) Kazakhstan
 * 36) Kenya
 * 37) Kyrgyzstan
 * 38) Laos
 * 39) Lebanon
 * 40) Libya
 * 41) Maldives
 * 42) Mali
 * 43) Mauritius
 * 44) Mexico
 * 45) Moldova
 * 46) Mongolia
 * 47) Montenegro
 * 48) Morocco
 * 49) Myanmar
 * 50) Namibia
 * 51) Nepal
 * 52) Nicaragua
 * 53) Nigeria
 * 54) North Macedonia
 * 55) Oman
 * 56) Pakistan
 * 57) Palestine
 * 58) Panama
 * 59) Paraguay
 * 60) Peru
 * 61) Philippines
 * 62) Rwanda
 * 63) Saint Vincent and the Grenadines
 * 64) San Marino
 * 65) Serbia
 * 66) Seychelles
 * 67) Sri Lanka
 * 68) Syria
 * 69) Tajikistan
 * 70) Tanzania
 * 71) Tunisia
 * 72) Turkey (limited use)
 * 73) United Arab Emirates
 * 74) Venezuela
 * 75) Vietnam
 * 76) Zimbabwe

Non-country entities
 * Abkhazia
 * South Ossetia


 * Expired
 * Slovakia
 * Rejected
 * South Africa
 * Travel-only
 * Australia
 * Cyprus
 * Estonia
 * Greece
 * Hong Kong
 * Israel
 * Malaysia
 * New Zealand
 * Saudi Arabia
 * Slovenia
 * St. Lucia
 * Thailand

CoronaVac
<section begin="coronavacauthmap"/>

<section end="coronavacauthmap"/> The CoronaVac COVID-19 vaccine is an inactivated virus vaccine produced by the Chinese company Sinovac Biotech.
 * Full (<section begin="CoronaVac_FN"/>1<section end="CoronaVac_FN"/>)
 * 1) China

Non-country entities
 * Hong Kong


 * Emergency (<section begin="CoronaVac_EN"/>71<section end="CoronaVac_EN"/>)
 * 1) Afghanistan
 * 2) Albania
 * 3) Algeria
 * 4) Argentina
 * 5) Armenia
 * 6) Azerbaijan
 * 7) Bangladesh
 * 8) Benin
 * 9) Bolivia
 * 10) Bosnia and Herzegovina
 * 11) Botswana
 * 12) Brazil
 * 13) Cambodia
 * 14) Chile
 * 15) Colombia
 * 16) Djibouti
 * 17) Dominica
 * 18) Dominican Republic
 * 19) East Timor
 * 20) Ecuador
 * 21) Egypt
 * 22) El Salvador
 * 23) Equatorial Guinea
 * 24) Fiji
 * 25) Gabon
 * 26) Georgia
 * 27) Guinea
 * 28) Guyana
 * 29) Hungary
 * 30) Indonesia
 * 31) Iraq
 * 32) Jordan
 * 33) Kazakhstan
 * 34) Kuwait
 * 35) Laos
 * 36) Lebanon
 * 37) Libya
 * 38) Malawi
 * 39) Malaysia
 * 40) Maldives
 * 41) Mexico
 * 42) Moldova
 * 43) Morocco
 * 44) Myanmar
 * 45) Nepal
 * 46) North Macedonia
 * 47) Oman
 * 48) Pakistan
 * 49) Palestine
 * 50) Panama
 * 51) Paraguay
 * 52) Philippines
 * 53) Qatar
 * 54) Rwanda
 * 55) Saint Vincent and the Grenadines
 * 56) Saudi Arabia
 * 57) Singapore
 * 58) Somalia
 * 59) South Africa
 * 60) Sri Lanka
 * 61) Sudan
 * 62) Syria
 * 63) Tajikistan
 * 64) Tanzania
 * 65) Thailand
 * 66) Togo
 * 67) Trinidad and Tobago
 * 68) Tunisia
 * 69) Turkey
 * 70) Turkmenistan
 * 71) Uganda
 * 72) Ukraine
 * 73) United Arab Emirates
 * 74) Uruguay
 * 75) Uzbekistan
 * 76) Venezuela
 * 77) Yemen
 * 78) Zimbabwe

Non-country entities
 * Northern Cyprus
 * World Health Organization


 * Travel-only


 * Andorra
 * Australia
 * Austria (only for entry)
 * Canada
 * Costa Rica
 * Croatia
 * Cyprus
 * Estonia (only if approved in a person's country of origin)
 * Finland
 * Greece
 * Grenada
 * Iceland
 * Ireland
 * Japan
 * Liechtenstein
 * Norway
 * New Zealand
 * Norway
 * Palau
 * Panama
 * Portugal (only in Madeira)
 * Slovakia
 * Slovenia
 * South Korea
 * Spain
 * St. Kitts and Nevis
 * St. Lucia
 * St. Vincent and the Grenadines
 * Sweden
 * Switzerland
 * The Netherlands
 * Ukraine
 * United Arab Emirates
 * United Kingdom
 * United States
 * Vietnam

Novavax
<section begin="NVXauthmap"/>

<section end="NVXauthmap"/> The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations.


 * Full (<section begin="Novavax_FN"/>4<section end="Novavax_FN"/>)
 * 1) Australia
 * 2) Canada
 * 3) Japan
 * 4) South Korea


 * Emergency (<section begin="Novavax_EN"/>57<section end="Novavax_EN"/>)
 * 1) Bangladesh
 * 2) India
 * 3) Indonesia
 * 4) Monaco
 * 5) New Zealand
 * 6) Philippines
 * 7) Singapore
 * 8) South Africa
 * 9) Switzerland
 * 10) Thailand
 * 11) Taiwan
 * 12) United Kingdom
 * 13) United States

EMA countries
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden

CARPHA countries and entities
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities
 * World Health Organization


 * Travel-only
 * Hong Kong
 * Palau
 * Panama
 * Switzerland
 * Turkey
 * United Arab Emirates
 * United States (before emergency approval July 2022)

Covaxin
<section begin="covaxinauthmap"/>

<section end="covaxinauthmap"/> Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech in collaboration with the Indian Council of Medical Research–National Institute of Virology.


 * Full (<section begin="Covaxin_EN"/>1<section end="Covaxin_EN"/>)
 * 1) India


 * Emergency (<section begin="Covaxin_EN"/>50<section end="Covaxin_EN"/>)
 * 1) Afghanistan
 * 2) Bahrain
 * 3) Botswana
 * 4) Central African Republic
 * 5) Comoros
 * 6) Egypt
 * 7) Ethiopia
 * 8) Guatemala (not used)
 * 9) Iran
 * 10) Iraq
 * 11) Jordan
 * 12) Kuwait
 * 13) Lebanon
 * 14) Libya
 * 15) Malaysia
 * 16) Mauritius
 * 17) Mexico (not used)
 * 18) Morocco
 * 19) Myanmar
 * 20) Nepal
 * 21) Nicaragua (not used)
 * 22) Oman
 * 23) Pakistan
 * 24) Paraguay
 * 25) Philippines
 * 26) Qatar
 * 27) Somalia
 * 28) Sudan
 * 29) Syria
 * 30) Tunisia
 * 31) United Arab Emirates
 * 32) Venezuela (not used)
 * 33) Vietnam
 * 34) Yemen
 * 35) Zimbabwe

CARPHA countries and entities
 * 1) Antigua and Barbuda
 * 2) Bahamas
 * 3) Barbados
 * 4) Belize
 * 5) Dominica
 * 6) Grenada
 * 7) Guyana (not used)
 * 8) Haiti
 * 9) Jamaica
 * 10) Saint Kitts and Nevis
 * 11) Saint Lucia
 * 12) Saint Vincent and the Grenadines
 * 13) Suriname
 * 14) Trinidad and Tobago
 * Anguilla
 * Aruba
 * British Virgin Islands
 * Bermuda
 * Caribbean Netherlands
 * Cayman Islands
 * Curaçao
 * Montserrat
 * Sint Maarten
 * Turks and Caicos Islands

Non-country entities
 * Palestine
 * World Health Organization
 * Travel-only


 * Andorra
 * Australia
 * Austria (only for entry)
 * Canada
 * Costa Rica
 * Croatia
 * Cyprus
 * Estonia (only if approved in a person's country of origin)
 * Finland
 * Greece
 * Hong Kong
 * Iceland
 * Ireland
 * Japan
 * Kyrgyzstan
 * Liechtenstein
 * Mongolia
 * New Zealand
 * Norway
 * Oman
 * Palestine
 * Palau
 * Panama
 * Portugal (only in Madeira)
 * Saudi Arabia
 * Singapore
 * Slovakia
 * Slovenia
 * South Korea
 * Spain
 * Sri Lanka
 * Sweden
 * Switzerland
 * Thailand
 * The Netherlands
 * Turkey
 * Ukraine
 * United Kingdom
 * United States

VLA2001
<section begin="vla2001authmap"/>

<section end="vla2001authmap"/> VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.


 * Full (<section begin="VLA2001_FN" />1<section end="VLA2001_FN" />)
 * 1) United Kingdom

EMA countries
 * Emergency (<section begin="VLA2001_EN" />32<section end="VLA2001_EN" />)
 * 1) Bahrain
 * 2) United Arab Emirates
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

Sanofi–GSK
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a subunit vaccine developed by Sanofi Pasteur and GSK plc. It is based on the SARS-CoV-2 Beta variant.

EMA countries (as booster only)
 * 1) Austria
 * 2) Belgium
 * 3) Bulgaria
 * 4) Croatia
 * 5) Cyprus
 * 6) Czech Republic
 * 7) Denmark
 * 8) Estonia
 * 9) Finland
 * 10) France
 * 11) Germany
 * 12) Greece
 * 13) Hungary
 * 14) Iceland
 * 15) Ireland
 * 16) Italy
 * 17) Latvia
 * 18) Liechtenstein
 * 19) Lithuania
 * 20) Luxembourg
 * 21) Malta
 * 22) Netherlands
 * 23) Norway
 * 24) Poland
 * 25) Portugal
 * 26) Romania
 * 27) Slovakia
 * 28) Slovenia
 * 29) Spain
 * 30) Sweden

Sputnik Light
<section begin="sputniklightauthmap"/>

<section end="sputniklightauthmap"/> Sputnik Light is a viral vector vaccine, produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.


 * Full (<section begin="Sputnik Light_FN"/>0<section end="Sputnik Light_FN"/>)


 * Emergency (<section begin="Sputnik Light_EN"/>28<section end="Sputnik Light_EN"/>)
 * 1) Angola
 * 2) Argentina
 * 3) Armenia
 * 4) Bahrain
 * 5) Belarus
 * 6) Benin
 * 7) Cambodia
 * 8) Congo-Brazzaville
 * 9) Egypt
 * 10) Iran
 * 11) India
 * 12) Kazakhstan
 * 13) Kyrgyzstan
 * 14) Laos
 * 15) Mauritius
 * 16) Mongolia
 * 17) Nicaragua
 * 18) Palestine
 * 19) Philippines
 * 20) Russia
 * 21) Saint Vincent and the Grenadines
 * 22) San Marino
 * 23) Syria
 * 24) Tanzania
 * 25) Tunisia
 * 26) Turkmenistan
 * 27) United Arab Emirates
 * 28) Venezuela

Non-country entities
 * Abkhazia
 * Donbass Region (unofficially)


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

Convidecia
<section begin="convideciaauthmap"/>

<section end="convideciaauthmap"/> Convidecia is a viral vector vaccine produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.


 * Full (<section begin="Convidecia_FN"/>1<section end="Convidecia_FN"/>)
 * 1) China


 * Emergency (<section begin="Convidecia_EN"/>9<section end="Convidecia_EN"/>)
 * 1) Argentina
 * 2) Chile
 * 3) Ecuador
 * 4) Hungary
 * 5) Indonesia
 * 6) Malaysia
 * 7) Mexico
 * 8) Moldova
 * 9) Pakistan

Non-country entities
 * World Health Organization
 * Travel-only
 * Hong Kong
 * Japan
 * New Zealand
 * Turkey

Sinopharm WIBP
The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.


 * Full (<section begin="Sinopharm-WIBP_FN"/>1<section end="Sinopharm-WIBP_FN"/>)
 * 1) China


 * Emergency (<section begin="Sinopharm-WIBP_EN"/>5<section end="Sinopharm-WIBP_EN"/>)
 * 1) Armenia
 * 2) North Macedonia
 * 3) Peru
 * 4) Philippines
 * 5) United Arab Emirates
 * 6) Venezuela


 * Travel-only
 * Hong Kong
 * Malaysia
 * New Zealand
 * Turkey

Abdala
<section begin="abdalaauthmap"/>

Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.


 * Full (<section begin="Abdala_FN"/>0<section end="Abdala_FN"/>)


 * Emergency (<section begin="Abdala_EN"/>6<section end="Abdala_EN"/>)
 * 1) Cuba
 * 2) Mexico
 * 3) Nicaragua
 * 4) St. Vincent and the Grenadines
 * 5) Venezuela
 * 6) Vietnam


 * Travel-only
 * Cambodia
 * Colombia
 * Guyana
 * Malaysia
 * New Zealand
 * St. Lucia
 * Turkey
 * Uruguay (only if accepted in the country of the person's origin)

EpiVacCorona
<section begin="epivac-coronaauthmap"/>

<section end="epivac-coronaauthmap"/> EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.


 * Full (<section begin="EpiVacCorona_FN"/>1<section end="EpiVacCorona_FN"/>)
 * 1) Turkmenistan


 * Emergency (<section begin="EpiVacCorona_EN"/>4<section end="EpiVacCorona_EN"/>)
 * 1) Belarus
 * 2) Cambodia
 * 3) Russia
 * 4) Venezuela


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

Zifivax
<section begin="rbd-dimerauthmap"/>

<section end="rbd-dimerauthmap"/> Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.


 * Full (<section begin="Zifivax_FN"/>0<section end="Zifivax_FN"/>)


 * Emergency (<section begin="Zifivax_EN"/>5<section end="Zifivax_EN"/>)
 * 1) China
 * 2) Colombia
 * 3) Indonesia
 * 4) Pakistan
 * 5) Uzbekistan


 * Travel-only
 * Hong Kong
 * Malaysia
 * New Zealand
 * Turkey

Soberana 02
<section begin="soberana2authmap"/>

<section end="soberana2authmap"/> Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.


 * Full (<section begin="Soberana 02_FN"/>0<section end="Soberana 02_FN"/>)


 * Emergency (<section begin="Soberana 02_EN"/>4<section end="Soberana 02_EN"/>)
 * 1) Cuba
 * 2) Iran
 * 3) Nicaragua
 * 4) Venezuela


 * Travel-only
 * Guyana
 * Hungary
 * Malaysia
 * New Zealand
 * Turkey

CoviVac
<section begin="covivacauthmap" />

<section end="covivacauthmap" /> CoviVac is an inactivated virus vaccine produced by the Chumakov Centre at the Russian Academy of Sciences.


 * Full (<section begin="CoviVac_FN" />0<section end="CoviVac_FN" />)


 * Emergency (<section begin="CoviVac_EN" />3<section end="CoviVac_EN" />)
 * 1) Belarus
 * 2) Cambodia
 * 3) Russia
 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

QazCovid-in
<section begin="qazcovid-inauthmap"/>

<section end="qazcovid-inauthmap"/> QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.
 * Full (<section begin="QazCovid-in_FN"/>0<section end="QazCovid-in_FN"/>)


 * Emergency (<section begin="QazCovid-in_EN"/>2<section end="QazCovid-in_EN"/>)
 * 1) Kazakhstan
 * 2) Kyrgyzstan


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

Minhai
<section begin="Minhaiauthmap"/>

<section end="Minhaiauthmap"/>Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.
 * Full (<section begin="Minhai_FN"/>0<section end="Minhai_FN"/>)


 * Emergency (<section begin="Minhai_EN"/>2<section end="Minhai_EN"/>)
 * 1) China
 * 2) Indonesia


 * Travel-only
 * Hong Kong
 * Malaysia
 * New Zealand
 * Turkey

Medigen
<section begin="medigenauthmap" />

<section end="medigenauthmap" /> MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.
 * Full (<section begin="Medigen_FN" />0<section end="Medigen_FN" />)


 * Emergency (<section begin="Medigen_EN" />3<section end="Medigen_EN" />)
 * 1) Eswatini
 * 2) Taiwan
 * 3) Paraguay

1. Somaliland
 * Non-country entities


 * Travel-only
 * Belize
 * Indonesia
 * Malaysia
 * New Zealand
 * Palau
 * Thailand
 * Turkey

Corbevax
Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.


 * Full (<section begin="Corbevax_FN" />0<section end="Corbevax_FN" />)


 * Emergency (<section begin="Corbevax_EN" />2<section end="Corbevax_EN" />)
 * 1) India
 * 2) Botswana


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

COVIran Barekat
COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.
 * Full (<section begin="COVIran Barakat_FN"/>0<section end="COVIran Barakat_FN"/>)


 * Emergency (<section begin="COVIran Barekat_EN"/>2<section end="COVIran Barekat_EN"/>)
 * 1) Iran
 * 2) Nicaragua


 * Travel-only
 * Malaysia
 * New Zealand
 * Hungary
 * Turkey
 * Turkey

Chinese Academy of Medical Sciences
Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences.
 * Full (<section begin="Chinese Academy of Medical Sciences_FN"/>0<section end="Chinese Academy of Medical Sciences_FN"/>)


 * Emergency (<section begin="Chinese Academy of Medical Sciences_EN"/>1<section end="Chinese Academy of Medical Sciences_EN"/>)
 * 1) China


 * Travel-only
 * Hong Kong
 * New Zealand
 * Turkey

ZyCoV-D
ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.
 * Full (<section begin="ZyCoV-D_FN"/>0<section end="ZyCoV-D_FN"/>)


 * Emergency (<section begin="ZyCoV-D_EN"/>1<section end="ZyCoV-D_EN"/>)
 * 1) India


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

FAKHRAVAC
FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.
 * Full (<section begin="FAKHRAVAC_FN"/>0<section end="FAKHRAVAC_FN"/>)


 * Emergency (<section begin="FAKHRAVAC_EN"/>1<section end="FAKHRAVAC_EN"/>)
 * 1) Iran


 * Travel-only
 * Hungary
 * Malaysia
 * New Zealand
 * Turkey

COVAX-19
COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.
 * Full (<section begin="COVAX-19_FN"/>0<section end="COVAX-19_FN"/>)


 * Emergency (<section begin="COVAX-19_EN"/>1<section end="COVAX-19_EN"/>)
 * 1) Iran


 * Travel-only
 * Hungary
 * Malaysia
 * New Zealand
 * Turkey

Razi Cov Pars
Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.
 * Full (<section begin="Razi Cov Pars_FN"/>0<section end="Razi Cov Pars_FN"/>)


 * Emergency (<section begin="Razi Cov Pars_EN"/>1<section end="Razi Cov Pars_EN"/>)
 * 1) Iran


 * Travel-only
 * Hungary
 * Malaysia
 * New Zealand
 * Turkey

Turkovac
Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.


 * Full (<section begin="TurkoVac_FN"/>0<section end="TurkoVac_FN"/>)


 * Emergency (<section begin="TurkoVac_EN"/>1<section end="TurkoVac_EN"/>)
 * 1) Turkey


 * Travel-only
 * Malaysia
 * New Zealand

Sinopharm CNBG
Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.


 * Full (<section begin="CNBG_FN"/>0<section end="CNBG_FN"/>)


 * Emergency (<section begin="CNBG_EN"/>1<section end="CNBG_EN"/>)
 * 1) United Arab Emirates


 * Travel-only
 * Malaysia
 * Turkey

Soberana Plus
Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.


 * Full (<section begin="Soberana Plus_FN"/>0<section end="Soberana Plus_FN"/>)


 * Emergency (<section begin="Soberana Plus_EN"/>2<section end="Soberana Plus_EN"/>)
 * 1) Belarus
 * 2) Cuba


 * Travel-only
 * Guyana
 * Malaysia
 * New Zealand
 * Turkey

CoVLP
CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name Covifenz.


 * Full (<section begin="CoVLP_FN" />1<section end="CoVLP_FN" />)
 * 1) Canada


 * Emergency (<section begin="CoVLP_EN" />0<section end="CoVLP_EN" />)


 * Travel-only
 * Malaysia
 * New Zealand
 * Turkey

Noora
Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.


 * Full (<section begin="Noora_FN" />0<section end="Noora_FN" />)


 * Emergency (<section begin="Noora_EN" />1<section end="Noora_EN" />)
 * 1) Iran


 * Travel-only
 * Malaysia
 * Turkey

SKYCovione
SKYCovione is a protein subunit vaccine developed by SK Bioscience.


 * Full (<section begin="SKYCovione_FN" />0<section end="SKYCovione_FN" />)


 * Emergency (<section begin="SKYCovione_EN" />1<section end="SKYCovione_EN" />)
 * 1) South Korea

Walvax
Walvax COVID-19 vaccine is an RNA vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science.


 * Full (<section begin="Walvax_FN" />0<section end="Walvax_FN" />)


 * Emergency (<section begin="Walvax_EN" />1<section end="Walvax_EN" />)
 * 1) Indonesia

iNCOVACC
iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat Biotech, Precision Virologics, and Washington University School of Medicine.


 * Full (<section begin="iNCOVACC_FN" />0<section end="iNCOVACC_FN" />)


 * Emergency (<section begin="iNCOVACC_EN" />1<section end="iNCOVACC_EN" />)
 * 1) India

Gemcovac
Gemcovac, or GEMCOVAC-19, is a self-amplifying mRNA vaccine manufactured by Gennova Biopharmaceuticals.


 * Full (<section begin="Gemcovac_FN" />0<section end="Gemcovac_FN" />)


 * Emergency (<section begin="Gemcovac_EN" />1<section end="Gemcovac_EN" />)
 * 1) India

V-01
V-01 is a protein subunit vaccine developed by Livzon Mabpharm.


 * Full (<section begin="V-01_FN" />0<section end="V-01_FN" />)


 * Emergency (<section begin="V-01_EN" />1<section end="V-01_EN" />)
 * 1) China

IndoVac
IndoVac is a protein subunit vaccine developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine.


 * Full (<section begin="IndoVac_FN" />0<section end="IndoVac_FN" />)


 * Emergency (<section begin="IndoVac_EN" />1<section end="IndoVac_EN" />)
 * 1) Indonesia